Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Meridian Small Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+9%
YTD-13%
Annualized+0.0861%
Positioning StanceCONSTRUCTIVE
Market CapSmallCap
Digest Analysis
Quick Take
"The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a core conviction in undervalued healthcare assets."
Executive Summary
For the quarter ended December 31, 2025, the Meridian Small Cap Growth Fund returned 0.90% (net), underperforming the Russell 2000 Growth Index's 1.22%. Despite macro-driven moderation, the portfolio benefited from its overweight allocation to healthcare, which was the quarter's primary contributor. Stock selection within IT detracted. Detractors included Consensus Cloud Solutions, Certara, and Remitly Global, all of which are viewed as fundamentally sound and attractively valued. Top contributors included Structure Therapeutics, Axogen, and Zenas BioPharma, supported by solid clinical trials and regulatory milestones. Moving into 2026, the fund is monitoring interest rate policy, the new Fed Chair appointment, and AI capex sustainability, while maintaining its consistent quality-first, risk-mitigating posture.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
80%
Market Conviction
High-conviction positioning: The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
80%
Growth Outlook
Market outlook remains above average conviction: The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
70%
Risk Appetite
Risk appetite posture is moderate conviction: The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
50%
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
80%
Forward Guidance
Forward guidance signal: The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
85%
Language Signal
Tone analysis indicates above average conviction language: The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
60%
Perceived Risk
Perceived risk level is evaluated as above average conviction. The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
70%
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...
80%
Time Horizon
Investment time horizon reflects a high conviction orientation. The Meridian Small Cap Growth Fund returned 0.90% in Q4 2025, underperforming its benchmark. It remains committed to a downside-protected, quality-biased approach, maintaining a co...